CG
IDXX icon

Cynosure Group’s Idexx Laboratories IDXX Stock Holding History

Cynosure Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Buy
852
+112
+15% +$62.8K 0.07% 152
2026
Q1 		$416K Buy
+740
New +$475K 0.05% 133
2025
Q1 		– Sell
-4,429
Closed -$1.83M – 386
2024
Q4 		$1.83M Buy
+4,429
New +$1.94M 0.27% 49
2024
Q3 		– Sell
-814
Closed -$397K – 384
2024
Q2 		$397K Buy
814
+157
+24% +$78.8K 0.06% 191
2024
Q1 		$355K Buy
+657
New +$359K 0.06% 162

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cynosure Group's IDXX Position: Q2 2026 in Review

Cynosure Group increased its Idexx Laboratories (IDXX) stake by 15% in Q2 2026, buying an estimated $62.8K and bringing the position to 852 shares worth $449K. The position accounts for 0.07% of the portfolio, ranked #152.

Cynosure Group first reported a position in IDXX in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.83M in Q4 2024. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cynosure Group held 852 shares of Idexx Laboratories worth $449K as of Q2 2026.
  • Cynosure Group bought 112 Idexx Laboratories shares in Q2 2026, an estimated $62.8K.
  • Idexx Laboratories made up 0.07% of Cynosure Group's portfolio in Q2 2026, its #152 holding.
  • Cynosure Group first reported a position in Idexx Laboratories in Q1 2024 and has held it in 5 quarters since.
  • Cynosure Group's Idexx Laboratories position peaked at $1.83M in Q4 2024.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.